{"id":"W4416331414","doi":"10.1158/1078-0432.ccr-25-2440","title":"Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen–Positive Advanced/Metastatic Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche; Roche","keywords":"Atezolizumab; Carcinoembryonic antigen; Pharmacodynamics; Solid tumor; Cancer; Pharmacokinetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007721065,0.0004854088,0.001385409,0.0002216232,0.0002266623,0.000445669,0.0003195772,0.0004084496,0.0006838835],"category_scores_gemma":[0.0007482579,0.0002297217,0.0006906389,0.0002662597,0.0003288877,0.0003665731,0.0001977321,0.001049733,0.0001741035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000590682,"about_ca_system_score_gemma":0.0007048599,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005042989,"about_ca_topic_score_gemma":0.001446426,"domain_scores_codex":[0.9996561,0.0001611655,0.00002792494,0.00004854657,0.00004765288,0.00005861164],"domain_scores_gemma":[0.9996102,0.00009121704,0.0001041221,0.0000245777,0.00002502691,0.0001448085],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4097138,0.02194977,0.1079067,0.0009503858,0.002462458,0.001587761,0.0005994579,0.006694018,0.1119854,0.0002600781,0.002627512,0.3332627],"study_design_scores_gemma":[0.1833876,0.6195074,0.1623529,0.0001214942,0.001768253,0.002685537,0.0001892239,0.006234092,0.01561493,0.0002660295,0.007813056,0.00005966602],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997519,0.001646515,0.0001413297,0.0001126856,0.00002303389,0.0001204953,0.00005111408,0.00001408766,0.000371708],"genre_scores_gemma":[0.9986994,0.0005270189,0.0002461268,0.0001308353,0.00003865435,0.00007378385,0.0001151302,0.000002836303,0.0001661404],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001385409,"threshold_uncertainty_score":0.004285693,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07898439884002029,"score_gpt":0.5006161356055636,"score_spread":0.4216317367655433,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}